Photodynamic diagnosis of gastrointestinal cancer using 5-aminolevulinic acid
Phase 2
Recruiting
- Conditions
- esophageal, gastric, colorectal, hepatocellular, cholangio, pancreatic or gallbladder cancerD004938, D013274, D015179, D006528, D018281, D010190, D005706
- Registration Number
- JPRN-jRCTs051180148
- Lead Sponsor
- Otsuji Eigo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients who diagnosed cancer by histological or cytological diagnosis. Patients scheduled for operation. Patients written consent has been obtained
Exclusion Criteria
porphyria patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess diagnostic value of photodynamic diagnosis using 5-ALA.
- Secondary Outcome Measures
Name Time Method To assess diagnostic value of urinary 5-ALA and its metabolite concentrations.